• Ms. Sneha
• Dr SP Subashini
• Mr. Devendra Kumar
• Ms. Akansha

Hepatitis B is a potentially life-threatening liver infection caused by the hepatitis B virus (HBV). It is a major global health problem. It can cause chronic infection and puts people at high risk of death from cirrhosis and liver cancer. A safe and effective vaccine that offers 98% to 100% protection against hepatitis B is available. Preventing hepatitis B infection averts the development of complications including chronic disease and liver cancer. The burden of hepatitis B infection is highest in the WHO Western Pacific Region and the WHO African Region, where 116 million and 81 million people, respectively, are chronically infected. Sixty million people are infected in the WHO Eastern Mediterranean Region, 18 million in the WHO South-East Asia Region, 14 million in the WHO European Region and 5 million in the WHO Region of the Americas.

Transmission, Risk factors, Clinical manifestations, Diagnosis, Reactivation, Screening, Nursing management, Medical management

"A Systematic Review on Hepatitis B", International Journal of Emerging Technologies and Innovative Research (www.jetir.org), ISSN:2349-5162, Vol.9, Issue 9, page no.a711-a718, September-2022, Available :http://www.jetir.org/papers/JETIR2209075.pdf

"A Systematic Review on Hepatitis B", International Journal of Emerging Technologies and Innovative Research (www.jetir.org | UGC and issn Approved), ISSN:2349-5162, Vol.9, Issue 9, page no. ppa711-a718, September-2022, Available at : http://www.jetir.org/papers/JETIR2209075.pdf